By Peter Nasca Perhaps the third time’s a charm? Several years ago, while I was pitching a story to a writer/editor, I was told I was persistent “to the point
Read More
By Julie Neitzel Many of us are familiar with Fortune magazine’s annual list of the 500 largest U.S. companies, which is a mark of prestige for those who are on
Read More
By Christine Alexis With football season underway, it’s a good time to consider the history of one of the sport’s iconic teams—the Miami Dolphins. They grew rapidly during their first
Read More
Rachel Sapoznik, who is on this month’s cover, is a business leader transcending what you would expect from someone in her line of work. I’ve had the pleasure to know
Read More
Why there’s a case for GM as a value gem — and a growth story. General Motors‘s (NYSE:GM) stock is trading at just 6.3 times GM’s expected 2017 earnings. That’s well below
Read More
Push your tax-favored savings to the limit with these tips. Many investors struggle to find any money to save toward retirement, but a few fortunate investors have more favorable financial
Read More
Income stocks don’t get more rock-solid than this. In many ways, you could think of dividend stocks as the financial foundation of your portfolio. The reason is that they bring
Read More
One proposal suggests changing taxes on 401K contributions to pay for corporate tax breaks. When Donald Trump campaigned for president, a staple of his platform was corporate tax reform. Since
Read More
The new iPhone is going to be a hit, but Apple shares still fell during Tuesday’s debut. Let’s break down the reasons it happened. Like a kid who gets every
Read More
You don’t build reusable rockets, try to disrupt the automotive industry, or dream up a new mode of high-speed travel without producing some amazing quotes along the way. Here are
Read More
Here’s a glimpse of the higher-end of the credit card market. There is a tremendous amount of variety in the credit card market, with products ranging from simple no-annual-fee credit cards with
Read More
If you’re concerned about a forthcoming market correction, GlaxoSmithKline, AT&T, and Procter & Gamble may be worth buying right now. Although the broader markets are currently trading at historic highs
Read More

